Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity

Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.

6,792 public trials 653 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity trial results

Completed

Clinical Assessment of Acupuncture for the Treatment of Chronic Asthma

NCT01931696

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • University Hospital of Gansu Traditional Chinese Medicine Lanzhou, Gansu, China
  • Kaifeng Traditional Chinese Medicine hospital Kaifeng, Henan, China
  • No.3 hospital of Henan college of Traditional Chinese Medicine Zhengzhou, Henan, China
  • Zhengzhou Traditional Chinese Medicine hospital Zhengzhou, Henan, China
View Trial Details
Completed

A Study to Evaluate Adverse Events and Change in Disease State of Oral Upadacitinib in Adolescent Participants Ages 12 to <18 Years Old Diagnosed With Atopic Dermatitis (AD)

NCT05029895

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Takeo Skin Clinic /ID# 248095 Asahi Owari, Aichi-ken, Japan
  • Ichinomiya Municipal Hospital /ID# 245070 Ichinomiya-shi, Aichi-ken, Japan
  • NHO Nagoya Medical Center /ID# 245069 Nagoya, Aichi-ken, Japan
  • Nagoya City University Hospital /ID# 250809 Nagoya, Aichi-ken, Japan
View all 61 locations
View Trial Details
Completed

Study to Investigate Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization With AIRSUPRA Compared to Albuterol as Needed in Adults With Mild Asthma

NCT06563102

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +7 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Tucson, Arizona, United States
  • Research Site Lancaster, California, United States
  • Research Site San Diego, California, United States
View all 16 locations
View Trial Details
Completed

A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With Asthma

NCT06261957

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site North Hollywood, California, United States
  • GSK Investigational Site San Mateo, California, United States
  • GSK Investigational Site Aventura, Florida, United States
  • GSK Investigational Site Clearwater, Florida, United States
View all 101 locations
View Trial Details
Completed

A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab

NCT05369403

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • River Region Dermatology and Laser Montgomery, Alabama, United States
  • Medical Dermatology Specialists Phoenix, Arizona, United States
  • First OC Dermatology Fountain Valley, California, United States
  • Axon Clinical Research Inglewood, California, United States
View all 37 locations
View Trial Details
Completed

ENHANCE-EvideNce Led Co-created HeAlth Systems interventioNs for MLTCs CarE

NCT06248190

Conditions
Asthma, Behavior, Behavioral Symptoms, +46 more
Locations
  • Eastwood Clinic Pietermaritzburg, KwaZulu-Natal, South Africa
  • Esigodini Clinic Pietermaritzburg, KwaZulu-Natal, South Africa
  • Gcumisa Clinic Pietermaritzburg, KwaZulu-Natal, South Africa
  • Gomane Clinic Pietermaritzburg, KwaZulu-Natal, South Africa
View all 32 locations
View Trial Details

Related conditions